MEFLOQUINE HYDROCHLORIDE (mefloquine hydrochloride) by Molecular Devices is clinical pharmacology. Approved for mild to moderate acute malaria caused by mefloquine-susceptible strains of p. First approved in 2002.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY
Worked on MEFLOQUINE HYDROCHLORIDE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.